Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)

NCT00557622 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped difficulty in achieving target enrollment numbers

Conditions

Post-Traumatic Stress Disorder
Stress Disorders, Post-Traumatic

Interventions

DRUG: paroxetine
OTHER: placebo

Sponsor

GlaxoSmithKline